Article Versions Notes

Abraham M-K, Jost E, Hohmann JD, Searle AK, Bongcaron V, Song Y, Wendel HP, Peter K, Krajewski S, Wang X. A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices. Pharmaceutics. 2021; 13(9):1504. https://doi.org/10.3390/pharmaceutics13091504

Abraham, Meike-Kristin, Elena Jost, Jan David Hohmann, Amy Kate Searle, Viktoria Bongcaron, Yuyang Song, Hans Peter Wendel, Karlheinz Peter, Stefanie Krajewski, and Xiaowei Wang. 2021. "A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices" Pharmaceutics 13, no. 9: 1504. https://doi.org/10.3390/pharmaceutics13091504

Abraham, M.-K., Jost, E., Hohmann, J. D., Searle, A. K., Bongcaron, V., Song, Y., Wendel, H. P., Peter, K., Krajewski, S., & Wang, X. (2021). A Recombinant Fusion Construct between Human Serum Albumin and NTPDase CD39 Allows Anti-Inflammatory and Anti-Thrombotic Coating of Medical Devices. Pharmaceutics, 13(9), 1504. https://doi.org/10.3390/pharmaceutics13091504